Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.0400 (-2.51%) ($5.0400 - $5.0400) on Wed. Mar. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.94% (three month average) | RSI | 51 | Latest Price | $5.0400(-2.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XLB(21%) TAN(57%) REMX(18%) XLP(55%) XLU(19%) | Factors Impacting CAPR price | CAPR will decline at least -3.97% in a week (0% probabilities). XRT(7%) IPO(-8%) INDA(1%) IWO(-4%) IWM(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.97% (StdDev 7.94%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $5.39 | 5 Day Moving Average | $5.19(-2.89%) | 10 Day Moving Average | $5.19(-2.89%) | 20 Day Moving Average | $5.39(-6.49%) | To recent high | -36.5% | To recent low | 0% | Market Cap | $99m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |